← Back to Search

Other

Active Laser Group (ALG) for Overactive Bladder (PLTOAB Trial)

N/A
Waitlist Available
Led By Ralph Zipper, MD
Research Sponsored by Zipper Urogynecology Associates
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visits 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 and 13 (over approximately 8 weeks)
Awards & highlights

PLTOAB Trial Summary

The primary objective of this study is to determine the effectiveness of transvaginally-delivered low level laser therapy (LLLT) versus Sham in the treatment of overactive bladder symptoms in women. The secondary objective is to determine the effect of transvaginally-delivered LLLT vs. sham on the quality of life.

Eligible Conditions
  • Overactive Bladder

PLTOAB Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visits 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 and 13 (over approximately 8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and visits 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 and 13 (over approximately 8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The primary efficacy endpoint will be the improvement of OAB symptoms and general quality of life due to the effect of LLLT treatment on OAB through week 7.
The primary safety endpoint will evaluate the SLG and ALG treatment groups for differences in reported side effects and adeverse events throughout the trial, including LLLT treatment and follow-up.

PLTOAB Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active Laser Group (ALG)Active Control1 Intervention
Group II: Sham Laser Group (SLG)Placebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Zipper Urogynecology AssociatesLead Sponsor
Ralph Zipper, MDPrincipal InvestigatorZipper Urogynecology Associates

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Painless Laser Therapy for Overactive Bladder
Ralph Zipper, MD 2012. "Painless Laser Therapy for Overactive Bladder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01569061.
All > Overactive Bladder
~15 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top